This work is licensed under the Creative Commons Attribution 4.0 International License.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: 10.3322/caac.21660SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2021712094910.3322/caac.21660Open DOISearch in Google Scholar
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74: 2913–21. doi: 10.1158/0008-5472.Can-14-0155RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States20147429132110.1158/0008-5472.Can-14-0155Open DOISearch in Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin 2021; 71: 7–33. doi: 10.3322/caac.21654SiegelRLMillerKDFuchsHEJemalACancer statistics20217173310.3322/caac.21654Open DOISearch in Google Scholar
Kommalapati A, Tella SH, Goyal G, Ma WW, Mahipal A. Contemporary management of localized resectable pancreatic cancer. Cancers 2018; 10: 24. doi: 10.3390/cancers10010024KommalapatiATellaSHGoyalGMaWWMahipalAContemporary management of localized resectable pancreatic cancer2018102410.3390/cancers10010024Open DOISearch in Google Scholar
Huang C, Chen J. Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma. Mol Med Rep 2021; 23: 11. doi: 10.3892/mmr.2020.11649HuangCChenJLaminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma2021231110.3892/mmr.2020.11649Open DOISearch in Google Scholar
Li R, Ochs MF, Ahn SM, Hennessey P, Tan M, Soudry E, et al. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma. PLoS One 2014; 9: e91263. doi: 10.1371/journal.pone.0091263LiROchsMFAhnSMHennesseyPTanMSoudryEExpression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma20149e9126310.1371/journal.pone.0091263Open DOISearch in Google Scholar
Shu C, Wang W, Wu L, Qi C, Yan W, Lu W, et al. LINC00936/microRNA-221-3p regulates tumor progression in ovarian cancer by interacting with LAMA3. Recent Pat Anticancer Drug Discov 2023; 18: 66–79. doi: 10.2174/1574892817666220316152201ShuCWangWWuLQiCYanWLuWLINC00936/microRNA-221-3p regulates tumor progression in ovarian cancer by interacting with LAMA3202318667910.2174/1574892817666220316152201Open DOISearch in Google Scholar
Xu SF, Zheng Y, Zhang L, Wang P, Niu CM, Wu T, et al. Long non-coding RNA LINC00628 interacts epigenetically with the LAMA3 promoter and contributes to lung adenocarcinoma. Mol Ther Nucleic Acids 2019; 18: 166–82. doi: 10.1016/j.omtn.2019.08.005XuSFZhengYZhangLWangPNiuCMWuTLong non-coding RNA LINC00628 interacts epigenetically with the LAMA3 promoter and contributes to lung adenocarcinoma2019181668210.1016/j.omtn.2019.08.005Open DOISearch in Google Scholar
Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, Yoshino H, et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 2012; 3: 1386–400. doi: 10.18632/oncotarget.709KinoshitaTHanazawaTNohataNKikkawaNEnokidaHYoshinoHTumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma20123138640010.18632/oncotarget.709Open DOISearch in Google Scholar
Bizama C, Benavente F, Salvatierra E, Gutiérrez-Moraga A, Espinoza JA, Fernández EA, et al. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Int J Cancer 2014; 134: 755–64. doi: 10.1002/ijc.28405BizamaCBenaventeFSalvatierraEGutiérrez-MoragaAEspinozaJAFernándezEAThe low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer20141347556410.1002/ijc.28405Open DOISearch in Google Scholar
Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep 2021; 11: 6047. doi: 10.1038/s41598-021-84787-5NagyÁMunkácsyGGyőrffyBPancancer survival analysis of cancer hallmark genes202111604710.1038/s41598-021-84787-5Open DOISearch in Google Scholar
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011; 378: 607–20. doi: 10.1016/s0140-6736(10)62307-0VincentAHermanJSchulickRHrubanRHGogginsMPancreatic cancer20113786072010.1016/s0140-6736(10)62307-0Open DOISearch in Google Scholar
Zboralski D, Böckmann M, Zapatka M, Hoppe S, Schöneck A, Hahn SA, et al. Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5). BMC Cancer 2008; 8: 215. doi: 10.1186/1471-2407-8-215ZboralskiDBöckmannMZapatkaMHoppeSSchöneckAHahnSADivergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5)2008821510.1186/1471-2407-8-215Open DOISearch in Google Scholar
Atay S. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues. Peer J 2020; 8: e10141. doi: 10.7717/peerj.10141AtaySIntegrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues20208e1014110.7717/peerj.10141Open DOISearch in Google Scholar
Chen J, Zhang H, Luo J, Wu X, Li X, Zhao X, et al. Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma. Oncol Lett 2018; 16: 199–210. doi: 10.3892/ol.2018.8678ChenJZhangHLuoJWuXLiXZhaoXOverexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma20181619921010.3892/ol.2018.8678Open DOISearch in Google Scholar
Xue K, Zheng H, Qian X, Chen Z, Gu Y, Hu Z, et al. Identification of key mRNAs as prediction models for early metastasis of pancreatic cancer based on LASSO. Front Bioeng Biotechnol 2021; 9: 701039. doi: 10.3389/fbioe.2021.701039XueKZhengHQianXChenZGuYHuZIdentification of key mRNAs as prediction models for early metastasis of pancreatic cancer based on LASSO2021970103910.3389/fbioe.2021.701039Open DOISearch in Google Scholar
Zheng B, Ohuchida K, Yan Z, Okumura T, Ohtsuka T, Nakamura M. Primary recurrence in the lung is related to favorable prognosis in patients with pancreatic cancer and postoperative recurrence. World J Surg 2017; 41: 2858–66. doi: 10.1007/s00268-017-4068-6ZhengBOhuchidaKYanZOkumuraTOhtsukaTNakamuraMPrimary recurrence in the lung is related to favorable prognosis in patients with pancreatic cancer and postoperative recurrence20174128586610.1007/s00268-017-4068-6Open DOISearch in Google Scholar